Bone mineral density is normal in children with Fanconi anemia

Pediatric Blood and Cancer

Volumn 57, Issue 6, 2011, Pages 1034-1038

  Rose, Susan R ^a   Rutter, Meilan M ^a   Mueller, Robin ^a   Harris, Michelle ^a   Hamon, Beth ^a   Bulluck, Arin Fletcher ^a   Smith, Franklin O ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Bone marrow failure; Bone mineral density; Delayed puberty; Fanconi anemia; Hematopoietic cell transplant; Outcomes research; Pediatric endocrinology; Small stature

Indexed keywords

ANDROGEN; GLUCOCORTICOID;

ADOLESCENT; ARTICLE; BODY HEIGHT; BONE DENSITY; BONE MATURATION; CHILD; CHRONIC DRUG ADMINISTRATION; CLINICAL ARTICLE; DUAL ENERGY X RAY ABSORPTIOMETRY; FANCONI ANEMIA; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LUMBAR SPINE; MALE; PRIORITY JOURNAL; PUBERTY;

ADOLESCENT; ADULT; BONE DENSITY; CHILD; CHILD, PRESCHOOL; FANCONI ANEMIA; FEMALE; HUMANS; MALE; YOUNG ADULT;

EID: 80052647100     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22956     Document Type: Article

References (35)

1. Neveling K, Endt D, Hoehn H, et al. Genotype-phenotype correlations in Fanconi anemia. Mutation Res 2009; 668: 73-91.
2. Wajnrajch MP, Gertner JM, Huma Z, et al. Evaluation of growth and hormonal status in patients referred to the International Fanconi Anemia Registry. Pediatrics 2001; 107: 744-754.
3. Sherafat-Kazemzadeh R, Mehta SN, Care MM, et al. Small pituitary size in children with Fanconi anemia. Pediatr Blood Cancer 2007; 49: 166-170.
4. Eyal O, Blum S, Mueller R, et al. Improved growth velocity during thyroid hormone therapy in children with Fanconi anemia and borderline thyroid function. Pediatr Blood Cancer 2008; 51: 652-656.
5. Elder DA, D'Alessio DA, Eyal O, et al. Abnormalities in glucose tolerance are common in children with Fanconi anemia and associated with impaired insulin secretion. Pediatr Blood Cancer 2008; 51: 256-260.
6. Baroncelli GI, Bertelloni S, Sodini F, et al. Longitudinal changes of lumbar bone mineral density (BMD) in patients with GH deficiency after discontinuation of treatment at final height; timing and peak values for lumbar BMD. Clin Endocrinol (Oxf) 2004; 60: 175-184.
7. Giri N, Batista DL, Alter BP, et al. Endocrine abnormalities in patients with Fanconi anemia. J Clin Endocrinol Metab 2007; 92: 2624-2631.
8. Petryk A, Bergemann TL, Polga KM, et al. Prospective study of changes in bone mineral density and turnover in children after hematopoietic cell transplantation. J Clin Endocrinol Metab 2006; 91: 899-905.
9. McClune BL, Polgreen LE, Burmeister LA, et al. Screening, prevention and management of osteoporosis and bone loss in adult and pediatric hematopoietic cell transplant recipients. Bone Marrow Transplant 2010; August 23 [Epub ahead of print]. pp 1-9.
10. Crofton PM. Bone and bone turnover. Endocr Dev 2009; 15: 77-100.
11. Lane NE, Yao W. Glucocorticoid-induced bone fragility. Ann NY Acad Sci 2010; 1192: 81-83.
12. Polgreen LE, Thomas W, MacMillan ML, et al. First phase insulin release and glucose tolerance in children with Fanconi anemia after hematopoietic cell transplantation. Pediatr Blood Cancer 2009; 53: 191-196.
13. Kalkwarf HJ, Gilsanz V, Lappe JM, et al. Tracking of bone mass and density during childhood and adolescence. J Clin Endocrinol Metab 2010; 95: 1690-1698.
14. Bianchi ML, Baim S, Bishop NJ, et al. Official positions of the International Society for Clinical Densitometry (ISCD) on DXA evaluation in children and adolescents. Pediatr Nephrol 2010; 25: 37-47.
15. Bachrach LK. Assessing bone health in children: Who to test and what does it mean? Pediatr Endocrinol Rev 2005; 2: 332-336.
16. Kalkwarf HJ, Zemel BS, Gilsanz V, et al. The bone mineral density in childhood study: Bone mineral content and density according to age, sex, and race. J Clin Endocrinol Metab 2007; 92: 2087-2099.
17. Gordon CM, Bachrach LK, Carpenter TO, et al. Dual energy X-ray absorptiometry interpretation and reporting in children and adolescents: The 2007 ISCD Pediatric Official Positions. J Clin Densitom 2008; 11: 43-58.
18. Bachrach LK, Hastie T, Wang MC, et al. Bone mineral acquisition in healthy Asian, Hispanic, black, and Caucasian youth: A longitudinal study. J Clin Endocrinol Metab 1999; 84: 4702-4712.
19. Willing MC, Torner JC, Burns TL, et al. Percentile distributions of bone measurements in Iowa children: The Iowa Bone Development Study. J Clin Densitom 2005; 8: 39-47.
20. Binkley TL, Berry R, Specker BL. Methods for measurement of pediatric bone. Rev Endocr Metab Disord 2008; 9: 95-106.
21. Petit MA, Beck TJ, Kontulainen SA. Examining the developing bone: What do we measure and how do we do it? J Musculoskelet Neuronal Interact 2005; 5: 213-224.
22. Fewtrell MS, Gordon I, Biassoni L, et al. Dual X-ray absorptiometry (DXA) of the lumbar spine in a clinical paediatric setting: Does the method of size-adjustment matter? Bone 2005; 37: 413-419.
23. Ahmed SF, Horrocks IA, Patterson T, et al. Bone mineral assessment by dual energy X-ray absorptiometry in children with inflammatory bowel disease: Evaluation by age or bone area. J Pediatr Gastroenterol Nutr 2004; 38: 276-280.
24. Henry YM, Fatayerji D, Eastell R. Attainment of peak bone mass at the lumbar spine, femoral neck and radius in men and women: Relative contributions of bone size and volumetric bone mineral density. Osteoporos Int 2004; 15: 263-273.
25. Bakalov VK, Chen ML, Baron J, et al. Bone mineral density and fractures in Turner syndrome. Am J Med 2003; 115: 259-264.
26. Zemel BS, Leonard MB, Kelly A, et al. Height adjustment in assessing dual energy X-ray absorptiometry measurements of bone mass and density in children. J Clin Endocrinol Metab 2010; 95: 1265-1273.
27. Pludowski P, Lebiedowski M, Lorenc RS. Evaluation of practical use of bone age assessments based on DXA-derived hand scans in diagnosis of skeletal status in healthy and diseased children. J Clin Densitom 2005; 8: 48-56.
28. Ruble K, Hayat M, Stewart KJ, et al. Bone mineral density after bone marrow transplantation in childhood: Measurement and associations. Biol Blood Marrow Transplant 2010; 16: 1451-1457.
29. Leonard MB, Bachrach LK. Assessment of bone mineralization following renal transplantation in children: Limitations of DXA and the confounding effects of delayed growth and development. Am J Transpl 2001; 1: 193-196.
30. Havill LM, Mahaney MC, Binkley TL, et al. Effects of genes, sex, age, and activity on BMC, bone size, and areal and volumetric BMD. J Bone Miner Res 2007; 22: 737-746.
31. Lane NE, Lukert B. The science and therapy of glucocorticoid-induced bone loss. Endocrinol Metab Clin North Am 1998; 27: 465-483.
32. Manias K, McCabe D, Bishop N, et al. Recurrent fractures in children; varying effects of environmental factors as well as bone size and mass. Bone 2006; 39: 652-657.
33. Bachrach LK. Dual energy X-ray absorptiometry (DEXA) measurements of bone density and body composition: Promise and pitfalls. J Pediatr Endocrinol Metab 2000; 13: 983-988.
34. Binkovitz LA, Henwood MJ. Pediatric DXA: Technique and interpretation. Pediatr Radiol 2007; 37: 21-31.
35. Wagner CL, Greer FR. Prevention of rickets and vitamin D deficiency in infants, children, and adolescents. Pediatrics 2008; 122: 1142-1152.